Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

Blurred Lines: Can Providers Become Drug Manufacturers?

Posted by Pratap Khedkar on Fri, Jan 26, 2018

Bill Coyle and Paul Darling co-authored this blog post with Pratap Khedkar.

The healthcare world had barely thought through the potential effects of the CVS/Aetna merger when news broke of another deal aiming to blur healthcare’s established business models: Four provider networks announced a nonprofit collaboration to manufacture generic drugs to keep prices down and lessen shortages. Skeptics have already pointed to considerable regulatory and manufacturing hurdles, so let’s focus on strategy and not implementation. If this DIY drug supply does start flowing, will it have its intended impact?

Read More

Topics: generics, healthcare provider networks, Bill Coyle, Pratap Khedkar, Paul Darling, pharma companies, collaboration, drug distribution, CVS/Aetna, drug manufacturing, branded drugs

Paging Dr. Watson: Evolving Pharmaceutical Value Propositions in the Age of Artificial Intelligence

Posted by Paul Darling on Thu, Dec 07, 2017

According to historical accounts, 19th-century English artist Sir Samuel Luke Fildes was determined to “put on record the status of the doctor of our time” when he painted “The Doctor,” a depiction of a concerned physician tending to his young patient. And though it was created in the midst of the Second Industrial Revolution, the artwork includes no sign of advancing medical technology. Instead, it presents what has become an iconic portrayal of patient-centered medical care.

Read More

Topics: customer insights, distribution, customer centricity, Pharma, contracting, artificial intelligence, value proposition, machine learning, drug distribution

Subscribe to The Active Ingredient


Subscribe to receive email notifications whenever new blog posts are published.